Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tavan Janvilisri

Showing results (61-70 of 89) with videos related to

Pageof 9
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|November 15, 2023
Unraveling Physical Interactions of Clostridioides difficile with Phage and Phage-Derived Proteins Using In Vitro and Whole-Cell AssaysWichuda Phothichaisri, Tanaporn Phetruen, Surang Chankhamhaengdecha, et al.
Antibiotics (Basel, Switzerland)|August 27, 2021
Teicoplanin Suppresses Vegetative <i>Clostridioides difficile</i> and Spore OutgrowthSuvash Chandra Ojha, Matthew Phanchana, Phurt Harnvoravongchai, et al.
The Journal of Infectious Diseases|May 20, 2011
Clostridium difficile transcriptome analysis using pig ligated loop model reveals modulation of pathways not modulated in vitroJoy Scaria, Tavan Janvilisri, Susan Fubini, et al.
Frontiers in Microbiology|August 16, 2018
Characterization of Bacteriophages Infecting Clinical Isolates of <i>Clostridium difficile</i>Wichuda Phothichaisri, Puey Ounjai, Tanaporn Phetruen, et al.
Antibiotics (Basel, Switzerland)|July 2, 2021
Temporal Variations in Patterns of <i>Clostridioides difficile</i> Strain Diversity and Antibiotic Resistance in ThailandSupapit Wongkuna, Tavan Janvilisri, Matthew Phanchana, et al.
Scientific Reports|December 29, 2024
Repurposing FDA-approved drugs targeting FZD10 in nasopharyngeal carcinoma: insights from molecular dynamics simulations and experimental validationChawalit Ngernsombat, Utid Suriya, Pongphol Prattapong, et al.
Diagnostic Microbiology and Infectious Disease|November 3, 2009
Development of a microarray for identification of pathogenic Clostridium sppTavan Janvilisri, Joy Scaria, Robin Gleed, et al.
Cancer Immunology, Immunotherapy : CII|May 7, 2026
αTrop2/αCD3 bispecific protein engager-armed T cells (BATs) exhibit potent antitumor activity against nasopharyngeal carcinomaKwanpirom Suwanchiwasiri, Chalermchai Somboonpatarakun, Nan Chaiyariti, et al.
Pharmaceuticals (Basel, Switzerland)|January 14, 2021
Co-Clinical Trials: An Innovative Drug Development Platform for CholangiocarcinomaBrinda Balasubramanian, Simran Venkatraman, Kyaw Zwar Myint, et al.
Plos One|January 7, 2021
Rapid detection of Clostridium perfringens in food by loop-mediated isothermal amplification combined with a lateral flow biosensorThanawat Sridapan, Wanida Tangkawsakul, Tavan Janvilisri, et al.
Pageof 9

Showing results (61-70 of 89) with videos related to

Sort By:
Pageof 9
Methods in Molecular Biology (Clifton, N.J.)|November 15, 2023
Unraveling Physical Interactions of Clostridioides difficile with Phage and Phage-Derived Proteins Using In Vitro and Whole-Cell AssaysWichuda Phothichaisri, Tanaporn Phetruen, Surang Chankhamhaengdecha, et al.
Antibiotics (Basel, Switzerland)|August 27, 2021
Teicoplanin Suppresses Vegetative <i>Clostridioides difficile</i> and Spore OutgrowthSuvash Chandra Ojha, Matthew Phanchana, Phurt Harnvoravongchai, et al.
The Journal of Infectious Diseases|May 20, 2011
Clostridium difficile transcriptome analysis using pig ligated loop model reveals modulation of pathways not modulated in vitroJoy Scaria, Tavan Janvilisri, Susan Fubini, et al.
Frontiers in Microbiology|August 16, 2018
Characterization of Bacteriophages Infecting Clinical Isolates of <i>Clostridium difficile</i>Wichuda Phothichaisri, Puey Ounjai, Tanaporn Phetruen, et al.
Antibiotics (Basel, Switzerland)|July 2, 2021
Temporal Variations in Patterns of <i>Clostridioides difficile</i> Strain Diversity and Antibiotic Resistance in ThailandSupapit Wongkuna, Tavan Janvilisri, Matthew Phanchana, et al.
Scientific Reports|December 29, 2024
Repurposing FDA-approved drugs targeting FZD10 in nasopharyngeal carcinoma: insights from molecular dynamics simulations and experimental validationChawalit Ngernsombat, Utid Suriya, Pongphol Prattapong, et al.
Diagnostic Microbiology and Infectious Disease|November 3, 2009
Development of a microarray for identification of pathogenic Clostridium sppTavan Janvilisri, Joy Scaria, Robin Gleed, et al.
Cancer Immunology, Immunotherapy : CII|May 7, 2026
αTrop2/αCD3 bispecific protein engager-armed T cells (BATs) exhibit potent antitumor activity against nasopharyngeal carcinomaKwanpirom Suwanchiwasiri, Chalermchai Somboonpatarakun, Nan Chaiyariti, et al.
Pharmaceuticals (Basel, Switzerland)|January 14, 2021
Co-Clinical Trials: An Innovative Drug Development Platform for CholangiocarcinomaBrinda Balasubramanian, Simran Venkatraman, Kyaw Zwar Myint, et al.
Plos One|January 7, 2021
Rapid detection of Clostridium perfringens in food by loop-mediated isothermal amplification combined with a lateral flow biosensorThanawat Sridapan, Wanida Tangkawsakul, Tavan Janvilisri, et al.
Pageof 9